Stockscreener 앱 받기
2.98
1.97%
-0.06
시간 외 거래:
2.98
전일 마감가:
$3.04
열려 있는:
$2.97
하루 거래량:
531.85K
Relative Volume:
1.18
시가총액:
$91.43M
수익:
$875.70K
순이익/손실:
$-39.57M
주가수익비율:
-2.2201
EPS:
-1.3423
순현금흐름:
$-33.65M
1주 성능:
-12.09%
1개월 성능:
-5.99%
6개월 성능:
+9.56%
1년 성능:
-0.67%
1일 변동 폭
$2.91
$3.03
1주일 범위
$2.84
$3.51
52주 변동 폭
$1.90
$3.88
Vistagen Therapeutics Inc Stock (VTGN) Company Profile
명칭
Vistagen Therapeutics Inc
전화
650-577-3600
주소
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
VTGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTGN
Vistagen Therapeutics Inc
|
2.98 | 93.27M | 875.70K | -39.57M | -33.65M | -1.3423 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-07 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-07-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-22 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-07-22 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-05-20 | 개시 | Robert W. Baird | Outperform |
| 2021-02-18 | 개시 | Jefferies | Buy |
| 2021-01-04 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-06-27 | 개시 | Maxim Group | Buy |
| 2018-02-08 | 재확인 | Chardan Capital Markets | Buy |
| 2017-03-28 | 개시 | Maxim Group | Buy |
모두보기
Vistagen Therapeutics Inc 주식(VTGN)의 최신 뉴스
Should I invest in Evotec SE Depositary Receipt before earningsSwing Trade & Stepwise Entry and Exit Trade Signals - khodrobank.com
Technical Analysis: What hedge funds are buying Vistagen Therapeutics IncDip Buying & Detailed Earnings Play Alerts - khodrobank.com
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Short Interest Up 55.7% in August - MarketBeat
What’s the recovery path for long term holders of Vistagen Therapeutics Inc.Dividend Hike & Intraday High Probability Alerts - newser.com
How moving averages guide Vistagen Therapeutics Inc. tradingQuarterly Market Review & Weekly Top Gainers Trade List - newser.com
Vistagen Therapeutics Inc. stock daily chart insightsBear Alert & Accurate Buy Signal Notifications - newser.com
Developing predictive dashboards with Vistagen Therapeutics Inc. dataEarnings Miss & Real-Time Chart Breakout Alerts - newser.com
Chart overlay techniques for tracking Vistagen Therapeutics Inc.Weekly Trend Summary & AI Driven Price Predictions - newser.com
Big Picture: Is Vistagen Therapeutics Inc a potential multi baggerJuly 2025 Opening Moves & Growth Oriented Trade Recommendations - khodrobank.com
Nasdaq Moves: What is the next catalyst for Vistagen Therapeutics IncTrade Analysis Summary & Growth Focused Stock Pick Reports - khodrobank.com
Macro Review: Is Vistagen Therapeutics Incs growth already priced in2025 Growth vs Value & Low Drawdown Momentum Trade Ideas - khodrobank.com
VistaGen at TD Cowen Summit: Advancing Neuropsychiatry Innovations By Investing.com - Investing.com Canada
Sector ETF performance correlation with Vistagen Therapeutics Inc.Inflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Can Vistagen Therapeutics Inc. stock double in the next yearJuly 2025 Trends & Consistent Profit Trading Strategies - khodrobank.com
Analyst Downgrade: What is Vistagen Therapeutics Incs valuation compared to sectorJuly 2025 Spike Watch & Target Return Focused Picks - khodrobank.com
Dow Update: Is Vistagen Therapeutics Incs growth already priced inPortfolio Performance Report & AI Driven Stock Movement Reports - khodrobank.com
Is Vistagen Therapeutics Inc a top pick in the sector2025 Historical Comparison & Fast Moving Trade Plans - khodrobank.com
Earnings Report: Is Vistagen Therapeutics Inc a potential multi baggerJuly 2025 Short Interest & High Yield Equity Trading Tips - khodrobank.com
- newser.com
Macro Review: Can Vistagen Therapeutics Inc. stock double in the next yearJuly 2025 Big Picture & Community Verified Trade Signals - khodrobank.com
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Short Interest Update - Defense World
How high can Vistagen Therapeutics Inc. stock goWeekly Loss Report & Weekly Watchlist of Top Performers - newser.com
Understanding Vistagen Therapeutics Inc.’s price movementStop Loss & Short-Term High Return Strategies - newser.com
Price Action: Why is Vistagen Therapeutics Inc stock going down2025 Trading Recap & Real-Time Stock Entry Alerts - خودرو بانک
Aug Shorts: What is the next catalyst for Vistagen Therapeutics IncMarket Volume Summary & Fast Momentum Stock Entry Tips - khodrobank.com
Vistagen Therapeutics CFO Cynthia L. Anderson resignsSEC filing - MarketScreener
Vistagen Therapeutics CFO Cynthia L. Anderson ResignsSEC Filing - TradingView
Quarterly Trades: Does TriNet Group Inc have pricing powerMarket Trend Review & Verified Entry Point Detection - khodrobank.com
Vistagen Therapeutics, Inc. Announces the Resignation of Cynthia L. Anderson as Principal Financial and Accounting Officer, Effective October 15, 2025 - MarketScreener
Is Vistagen Therapeutics Inc. a top pick in the sectorJuly 2025 Drop Watch & Smart Investment Allocation Insights - خودرو بانک
Investment Recap: Why is Vistagen Therapeutics Inc stock going downIPO Watch & Consistent Income Trade Ideas - khodrobank.com
Tools to monitor Vistagen Therapeutics Inc. recovery probabilityJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
Is a relief rally coming for Vistagen Therapeutics Inc. holders2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
How to manage a losing position in Vistagen Therapeutics Inc.Weekly Gains Report & Smart Money Movement Tracker - Newser
Price action breakdown for Vistagen Therapeutics Inc.Weekly Loss Report & High Conviction Trade Alerts - Newser
What Fibonacci levels say about Vistagen Therapeutics Inc. reboundWeekly Risk Report & AI Forecast Swing Trade Picks - Newser
Risk vs reward if holding onto Vistagen Therapeutics Inc.Share Buyback & Technical Entry and Exit Tips - Newser
Regression analysis insights on Vistagen Therapeutics Inc. performancePortfolio Performance Summary & Free Long-Term Investment Growth Plans - Newser
Forecasting Vistagen Therapeutics Inc. price range with options dataJuly 2025 Drop Watch & Daily Stock Trend Reports - Newser
Vistagen Therapeutics Inc (VTGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
0.09%
자본화:
|
볼륨(24시간):